Summary by Futu AI
Jun Sung Tai Pharmaceutical-B (stock code 02511), a limited company incorporated in the Cayman Islands, filed the Monthly Report of Changes in Shares with Hong Kong Trading and Settlement Limited on 4 January 2024. The report shows that as of December 31, 2023, the company's regulated/registered share capital remained at 1,000,000,000 shares with a face value of $0.0001 per share, totaling $100,000, the same as the number deposited at the end of the previous month. The company's ordinary shares were listed on the main board of the Hong Kong Stock Exchange Limited on 22 December 2023. The report does not show any increase or decrease in shares this month, nor does it involve changes in stock options, warrants, convertible notes or other agreements. The Company confirms that all relevant listing prerequisites have been met and that all legal requirements have been complied with.